SEC filing · 8-K

Vaxcyte, Inc.: Material agreement

Vaxcyte completed concurrent public offerings of convertible senior notes and common stock to raise capital.

Filed October 9, 2026

Positive for the company

What happened

Vaxcyte issued $575,000,000 aggregate principal amount of 1.50% Convertible Senior Notes due 2032.

The full interpretation is in the app

Why it matters, the key numbers from the document and what to watch next: the full interpretation of every report is part of Pro.

Read the full interpretation

Read the original

Filing document on SEC.gov All documents of this filing

Back to Vaxcyte, Inc.

Summary generated automatically from the filing text and checked against it: every number above is printed in the document. It describes the filing and is not investment advice. Read the original before relying on it.